BIOMAT Database Logo BIOMAT Database Logo

L-alpha-methyl-dopa versus the racemic form--a comparative study of the hypotensive effect. 1966

K Alestig, and R Sannerstedt

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Alestig, and R Sannerstedt
[A new-type hypotensive agent: alpha-methyl-DOPA].
January 1962, Actualites cardiologiques et angeiologiques internationales,
K Alestig, and R Sannerstedt
[Methyl-dopa and mebutamate. Hypotensive action of guanethidine. Comparative study].
January 1963, Prensa medica argentina,
K Alestig, and R Sannerstedt
Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.
January 1974, New York state journal of medicine,
K Alestig, and R Sannerstedt
[alpha-Methyl-dopa, new drug with hypotensive action].
September 1962, Bollettino chimico farmaceutico,
K Alestig, and R Sannerstedt
[CLINICAL EXPERIENCE WITH A NEW HYPOTENSIVE DRUG: ALPHA-METHYL-DOPA].
July 1963, La Clinica terapeutica,
K Alestig, and R Sannerstedt
BEHAVIORAL EFFECTS OF L-ALPHA METHYL DOPA.
April 1965, Life sciences (1962),
K Alestig, and R Sannerstedt
Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
February 1974, Journal of medicinal chemistry,
K Alestig, and R Sannerstedt
On the localization of the hypotensive effect of L-dopa.
June 1972, The Journal of pharmacy and pharmacology,
K Alestig, and R Sannerstedt
L-ALPHA-METHYL-DOPA IN HYPERTENSION: A PRELIMINARY REPORT.
November 1963, Medical times,
K Alestig, and R Sannerstedt
The effect of l-dopa and alpha-methyl-dopa on C cell secretion in the thyroid gland.
January 1977, Acta medica Polona,
Copied contents to your clipboard!